Bristol Myers Squibb (BMY)

Change in Working Capital

-$624.00M

Quarterly · Period ending: · USD

BMY logo

BMY Change in Working Capital

Latest reported-$624.00M
BMY Quarterly Change in Working Capital (-$109.00M → -$624.00M)
High-resolution chart · PNG

BMY change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
178,000,000
-624,000,000
470,000,000
-244,000,000
-319,000,000
-702,000,000
397,000,000
-172,000,000
-221,000,000
-478,000,000
90,000,000
192,000,000
-531,000,000
-196,000,000
-434,000,000
-154,000,000
-500,000,000
-265,000,000
-167,000,000
-121,000,000
-151,000,000
-237,000,000
-597,000,000
-12,000,000
-374,000,000
-4,000,000
-294,000,000
-228,000,000
-135,000,000
20,000,000
-79,000,000
118,000,000
0
-248,000,000
-89,000,000
18,000,000
-256,000,000
-222,000,000
107,000,000
-133,000,000
-255,000,000
-193,000,000
-2,000,000
-82,000,000
-170,000,000
-109,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.